Gonadotropin Releasing Hormone Receptor Agonist

This page covers all Gonadotropin Releasing Hormone Receptor Agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Gonadotropin-releasing hormone receptor, GnRH receptors, pituitary gonadotropin secretion.

Targets

Gonadotropin-releasing hormone receptor · GnRH receptors · pituitary gonadotropin secretion

Marketed (7)

• Lupron · Accord Healthcare S.L.U. · Oncology
  Lupron works by binding to and activating the gonadotropin-releasing hormone receptor, which ultimately leads to a decrease in the production of sex hormones.
• Zoladex · Tersera · Oncology
  Zoladex works by mimicking the body's natural hormone to reduce testosterone production.
• Lupron · Accord Healthcare S.L.U. · Oncology
  Leuprolide acetate, a long-acting GnRH analog, initially stimulates then suppresses pituitary gonadotropins, reducing gonadal steroid secretion.
• Vantas · Oncology
  Vantas works by binding to the gonadotropin-releasing hormone receptor, mimicking the natural hormone and reducing the production of sex hormones.
• Trelstar · Verity · Oncology
  Trelstar works by binding to and activating the gonadotropin-releasing hormone receptor, which leads to a decrease in testosterone production.
• Synarel · Pfizer · Other
• Zoladex · Tersera · Oncology
  ZOLADEX inhibits pituitary gonadotropin secretion, leading to regression or inhibition of hormonally sensitive tumors.